Style | Citing Format |
---|---|
MLA | Omraninava M, et al.. "Association Between Il7 Receptor Alpha (Il7ra) Gene Rs6897932 Polymorphism and the Risk of Multiple Sclerosis: A Meta-Regression and Meta-Analysis.." Multiple Sclerosis and Related Disorders, vol. 48, no. , 2021, pp. -. |
APA | Omraninava M, Mehranfar S, Vahedi P, Razi B, Imani D, Aslani S, Feyzinia S (2021). Association Between Il7 Receptor Alpha (Il7ra) Gene Rs6897932 Polymorphism and the Risk of Multiple Sclerosis: A Meta-Regression and Meta-Analysis.. Multiple Sclerosis and Related Disorders, 48(), -. |
Chicago | Omraninava M, Mehranfar S, Vahedi P, Razi B, Imani D, Aslani S, Feyzinia S. "Association Between Il7 Receptor Alpha (Il7ra) Gene Rs6897932 Polymorphism and the Risk of Multiple Sclerosis: A Meta-Regression and Meta-Analysis.." Multiple Sclerosis and Related Disorders 48, no. (2021): -. |
Harvard | Omraninava M et al. (2021) 'Association Between Il7 Receptor Alpha (Il7ra) Gene Rs6897932 Polymorphism and the Risk of Multiple Sclerosis: A Meta-Regression and Meta-Analysis.', Multiple Sclerosis and Related Disorders, 48(), pp. -. |
Vancouver | Omraninava M, Mehranfar S, Vahedi P, Razi B, Imani D, Aslani S, et al.. Association Between Il7 Receptor Alpha (Il7ra) Gene Rs6897932 Polymorphism and the Risk of Multiple Sclerosis: A Meta-Regression and Meta-Analysis.. Multiple Sclerosis and Related Disorders. 2021;48():-. |
BibTex | @article{ author = {Omraninava M and Mehranfar S and Vahedi P and Razi B and Imani D and Aslani S and Feyzinia S}, title = {Association Between Il7 Receptor Alpha (Il7ra) Gene Rs6897932 Polymorphism and the Risk of Multiple Sclerosis: A Meta-Regression and Meta-Analysis.}, journal = {Multiple Sclerosis and Related Disorders}, volume = {48}, number = {}, pages = {-}, year = {2021} } |
RIS | TY - JOUR AU - Omraninava M AU - Mehranfar S AU - Vahedi P AU - Razi B AU - Imani D AU - Aslani S AU - Feyzinia S TI - Association Between Il7 Receptor Alpha (Il7ra) Gene Rs6897932 Polymorphism and the Risk of Multiple Sclerosis: A Meta-Regression and Meta-Analysis. JO - Multiple Sclerosis and Related Disorders VL - 48 IS - SP - EP - PY - 2021 ER - |